Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2025-12-25 @ 9:59 PM
Study NCT ID:
NCT05815758
Status:
COMPLETED
Last Update Posted:
2025-07-10
First Post:
2023-03-21
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution
Sponsor:
Bausch & Lomb Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04-20
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-18
Completion Date Type:
ACTUAL
First Submit Date:
2023-03-21
First Submit QC Date:
None
Study First Post Date:
2023-04-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-12-10
Results First Submit QC Date:
None
Results First Post Date:
2025-07-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-20
Last Update Post Date:
2025-07-10
Last Update Post Date Type:
ACTUAL